Bortezomib Injection IP

Bortezomib Injection IP Specification

Application
Other

Physical Color/Texture
Tan liquid

Fermentation Smell
Normal Smell

Storage Instructions
Dry place

Shelf Life
upto 24 Months

Bortezomib Injection IP Trade Information

Minimum Order Quantity
1 Unit

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Units Per Month

Delivery Time
7-10 Days

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

Main Domestic Market
All India

About Bortezomib Injection IP

Discover the monumental efficacy of Bortezomib Injection IP (Bortenat), highlighted for its treatment of multiple myeloma and mantle-cell lymphoma. Proudly made in India, this top-grade tan liquid features a normal fermentation smell and comes in a single 3.5mg vial. With a venerable shelf life of up to 24 months and clear storage instructions for dry places, this injectable solution assures top-notch quality at the lowest price. Trusted by healthcare professionals, we serve as a valiant exporter and wholesaler committed to excellence.

Bortezomib Injection IP: Key Features and Competitive Advantages

Bortezomib Injection IP is primarily used by oncologists and healthcare providers treating multiple myeloma and mantle-cell lymphoma. Its top competitive advantages include a highlighted 24-month shelf life, robust efficacy, and reliable composition. Features such as a tan liquid appearance and normal odor ensure ease of recognition and safety. As an Indian-made product, its global reputation and economic packaging make it a top choice for medical institutions.

Delivery, Supply, and Purchase Information for Bortezomib Injection IP

Our rate quotations for Bortezomib Injection IP are competitive, ensuring accessible procurement for all buyers. Delivery times are typically swift, with FOB ports based in major Indian cities for streamlined export. We maintain a solid supply ability to fulfill purchase orders reliably. To receive a detailed quotation and confirm supply timelines, simply submit your purchase order, and we will manage the rest efficiently.

Specification

Country of Origin	Made in India
Packaging Size	3.5 mg X 1 Vial
Prescription/Non prescription	Prescription
Treatment	Multiple myeloma Mantle-cell lymphoma
Composition	Bortezomib (3.5mg)
Brand	Bortenat

FAQ's of Bortezomib Injection IP:

Q: How should Bortezomib Injection IP be stored for maximum shelf life?

A: Bortezomib Injection IP should be stored in a dry place away from sunlight and moisture to ensure its shelf life of up to 24 months is maintained.

Q: What conditions is Bortezomib Injection IP primarily used to treat?

A: Bortezomib Injection IP is primarily prescribed for the treatment of multiple myeloma and mantle-cell lymphoma, under the guidance of a healthcare provider.

Q: When can I expect delivery after placing a purchase order for Bortezomib Injection IP?

A: Delivery times for Bortezomib Injection IP are prompt; specific timelines depend on the destination and are shared at the time of rate quotation and order confirmation.

Q: Where is Bortezomib Injection IP manufactured and exported from?

A: Bortezomib Injection IP is manufactured in India and exported to various countries, with major FOB ports located in large Indian cities.

Q: What are the distinguishing features of Bortezomib Injection IP?

A: The injection is a tan liquid with a normal fermentation smell, packaged in a 3.5 mg single vial and noted for its top-notch quality and shelf stability.

Q: How is Bortezomib Injection IP supplied and what is the supply capacity?

A: We provide Bortezomib Injection IP in bulk for both wholesalers and exporters, with a resilient supply chain to meet large purchase orders efficiently.

Q: What benefits can medical professionals expect from using Bortezomib Injection IP?

A: Bortezomib Injection IP offers healthcare professionals a monumental advantage in cancer care with its reliable efficacy, extended shelf life, and economic pricing.